MetLife Investment Management’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $873K | Buy |
33,589
+1,774
| +6% | +$46.1K | 0.01% | 1377 |
|
|
2025
Q1 | $779K | Buy |
31,815
+2,789
| +10% | +$68.3K | ﹤0.01% | 1487 |
|
|
2024
Q4 | $832K | Buy |
29,026
+1,894
| +7% | +$54.3K | ﹤0.01% | 1511 |
|
|
2024
Q3 | $1.02M | Buy |
27,132
+13,780
| +103% | +$520K | 0.01% | 1378 |
|
|
2024
Q2 | $422K | Buy |
13,352
+1,246
| +10% | +$39.3K | ﹤0.01% | 1820 |
|
|
2024
Q1 | $531K | Buy |
+12,106
| New | +$531K | ﹤0.01% | 1638 |
|